Daily US COVID-19 Cases Up By 10 percent; J&J Jab Works Against Delta Variant

Health experts say that new instances of COVID-19 are on the rise compared to last week as the Delta version spreads across the United States.

COVID-19 Update: FDA Authorizes Shelf-Life Extension of Johnson & Johnson Vaccine as Some Doses are Set to Expire; and More - Docwire News


The weekly average of new daily cases was 10% higher, even though instances were down 95% from the nation’s peak in January, Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said in a briefing.

The Delta variant, which is said to have originated in India and is more contagious, is the second-most prevalent variant circulating in the U.S. and is expected to become the most common “in the coming weeks,” Walensky warned.

“As we prepare for Independence Day, I want to remind those who remain unvaccinated to protect themselves by wearing a mask, and avoid crowds to prevent transmission and illness,” she said.

The United States falls short of its pledge to provide vaccinations to the rest of the globe.

President Joe Biden fell well short of his target of providing 80 million vaccination shots to the rest of the globe by the end of June.

According to the White House, logistical and regulatory challenges have delayed the pace of US vaccine diplomacy. The Biden administration stated that around 50 nations and businesses will get a portion of the extra COVID-19 vaccination doses.

However, according to an Associated Press calculation, the United States has sent fewer than 24 million doses to 10 recipient countries. More will be delivered in the coming days, according to the White House.